Acute physiological and behavioral effects of intranasal methamphetamine in humans

Neuropsychopharmacology

Volumn 33, Issue 8, 2008, Pages 1847-1855

  Hart, Carl L ^a,b   Gunderson, Erik W ^a   Perez, Audrey ^a   Kirkpatrick, Matthew G ^a,b   Thurmond, Andrew ^a   Comer, Sandra D ^a   Foltin, Richard W ^a  

^a Columbia University ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Cognitive performance; Methamphetamine abuse; Mood; Plasma

Indexed keywords

LACTOSE; METHAMPHETAMINE; PLACEBO;

ADULT; ARTICLE; BEHAVIOR; CARDIOVASCULAR SYSTEM; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; DRUG DEPENDENCE; DRUG DOSE COMPARISON; DRUG MECHANISM; FEMALE; HOSPITAL PATIENT; HUMAN; MALE; PRIORITY JOURNAL; PSYCHOMOTOR PERFORMANCE; SINGLE DRUG DOSE; TASK PERFORMANCE;

ADMINISTRATION, INTRANASAL; ADULT; AMPHETAMINE-RELATED DISORDERS; BEHAVIOR; BLOOD PRESSURE; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; DATA INTERPRETATION, STATISTICAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; HEART RATE; HUMANS; MALE; METHAMPHETAMINE; PSYCHOMOTOR PERFORMANCE; QUESTIONNAIRES;

EID: 45149115594     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.npp.1301578     Document Type: Article

References (39)

1. Angrist B (1994). Amphetamine psychosis: clinical variations of the syndrome. In: Cho AK, Segal DS (eds). Amphetamine and its Analogues. Academic Press: San Diego. pp 387-414.
2. Cho AK, Melega WP, Kuczenski R, Segal DS (2001). Relevance of pharmacokinetic parameters in animal models of methamphetamine abuse. Synapse 39: 161-166.
3. Comer SD, Collins ED, Fischman MW (1997). Choice between money and intranasal heroin in morphine-maintained humans. Behav Pharmacol 6: 677-690.
4. Comer SD, Haney M, Foltin RW, Fischman MW (1996). Amphetamine self-administration by humans: modulation by contingencies associated with task performance. Psychopharmacology 127: 39-46.
5. Comer SD, Hart CL, Ward AS, Haney M, Foltin RW, Fischman MW (2001). Effects of repeated oral methamphetamine administration in humans. Psychopharmacology 155: 397-404.
6. Community Epidemiology Work Group (CEWG) (2005). Epidemiologic Trends in Drug Abuse Volume I: Proceedings of the Community Epidemiology Work Group, NIH Pub. No. 05-5364A US Government Printing Office: Washington, DC.
7. Community Epidemiology Work Group (CEWG) (2007). Epidemiologic Trends in Drug Abuse Volume I: Proceedings of the Community Epidemiology Work Group, NIH Pub. No. 07-5879A US Government Printing Office: Washington, DC.
8. Cook CE, Jeffcoat AR, Hill JM, Pugh DE, Patetta PK, Sadler BM et al (1993). Pharmacokinetics of methamphetamine self-administered to human subjects by smoking S-(+)-methamphetamine hydrochloride. Drug Metab Dispos 21: 717-723.
9. Domier CP, Simon SL, Rawson RA, Huber A, Ling W (2000). A comparison of injecting and noninjecting methamphetamine users. J Psych Drug 32: 229-232.
10. Foltin RW, Fischman MW, Pedroso JJ, Pearlson GD (1988). Repeated intranasal cocaine administration: lack of tolerance to pressor effects. Drug Alcohol Depend 22: 169-177.
11. Foltin RW, Haney M (2004). Intranasal cocaine in humans: acute tolerance, cardiovascular and subjective effects. Pharmacol Biochem Behav 78: 93-101.
12. Gawin FH, Khalsa-Denison ME (1996). Is craving mood-driven or self-propelled? Sensitization and 'street' stimulant addiction? NIDA Res Monogr 163: 224-250.
13. Halkitis PN, Parsons JT, Wilton L (2003). An exploratory study of contextual and situational factors related to methamphetamine use among gay and bisexual men in New York City. J Drug Issues 33: 413-432.
14. Harris DS, Boxenbaum H, Everhart ET, Sequeira G, Mendelson JE, Jones RT (2003). The bioavailability of intranasal and smoked methamphetamine. Clin Pharmacol Ther 74: 475-486.
15. Hart CL, Haney M, Foltin RW, Fischman MW (2002). Effects of the NMDA antagonist memantine on human methamphetamine discrimination. Psychopharmacology 164: 376-384.
16. Hart CL, Haney M, Nasser J, Foltin RW (2005). Combined effects of methamphetamine and zolpidem on behavior of shift workers. Pharmacol Biochem Behav 81: 559-568.
17. Hart CL, Haney M, Vosburg SK, Comer SD, Gunderson EW, Foltin RW (2006). Modafinil attenuates disruptions in cognitive performance during simulated night shift work. Neuropsychopharmacology 31: 1526-1536.
18. Hart CL, van Gorp WG, Haney M, Foltin RW, Fischman MW (2001b). Effects of acute smoked marijuana on complex cognitive performance. Neuropsychopharmacology 25: 757-765.
19. Hart CL, Ward AS, Haney M, Foltin RW, Fischman MW (2001a). Methamphetamine self-administration by humans. Psychopharmacology 157: 75-81.
20. Hart CL, Ward AS, Haney M, Nasser J, Foltin RW (2003). Methamphetamine attenuates disruptions in performance and mood during simulated night shift work. Psychopharmacology 169: 42-51.
21. Hatsukami DK, Fischman MW (1996). Crack cocaine and cocaine hydrochloride. Are the differences myth or reality? JAMA 276: 1580-1588.
22. Johnson BA, Ait-Daoud N, Wells LT (2000). Effects of isradipine, a dihydropyridine-class calcium channel antagonist, on D-methamphetamine-induced cognitive and physiological changes in humans. Neuropsychopharmacology 22: 504-512.
23. Johnson BA, Roache JD, Ait-Daoud N, Wallace C, Wells L, Dawes M et al (2005a). Effects of isradipine, a dihydropyridine-class calcium-channel antagonist, on d-methamphetamine's subjective and reinforcing effects. Int J Neuropsychopharmacol 8: 203-213.
24. Johnson BA, Roache JD, Ait-Daoud N, Wallace C, Wells LT, Wang Y (2005b). Effects of isradipine on methamphetamine-induced changes in attentional and perceptual-motor skills of cognition. Psychopharmacology 178: 296-302.
25. Johnson BA, Roache JD, Bordnick PS, Ait-Daoud N (1999). Isradipine, a dihydropyridine-class calcium channel antagonist, attenuates some of d-methamphetamine's positive subjective effects: a preliminary study. Psychopharmacology 144: 295-300.
26. Jones HE, Garrett BE, Griffiths RR (2001). Reinforcing effects of oral cocaine: contextual determinants. Psychopharmacology 154: 143-152.
27. Kelly TH, Foltin RW, Emurian CS, Fischman MW (1993). Performance-based testing for drugs of abuse: dose and time profiles of marijuana, amphetamine, alcohol, and diazepam. J Anal Toxicol 17: 264-272.
28. McLeod DR, Griffiths RR, Bigelow GE, Yingling J (1982). An automated version of the digit symbol substitution test (DSST). Behav Res Methods Instrum 14: 463-466.
29. Mendelson J, Jones RT, Upton R, Jacob P (1995). Methamphetamine and ethanol interactions in humans. Clin Pharmacol Ther 57: 559-568.
30. Miller TP, Taylor JL, Tinklenberg JR (1988). A comparison of assessment techniques measuring the effects of methylphenidate, secobarbital, diazepam, and diphenhydramine in abstinent alcoholics. Neuropsychobiology 19: 90-96.
31. Newton TF, De La Garza II R, Fong T, Chiang N, Holmes TH, Bloch DA et al (2005). A comprehensive assessment of the safety of intravenous methamphetamine administration during treatment with selegiline. Pharmacol Biochem Behav 82: 704-711.
32. Newton TF, Roache JD, De La Garza II R, Fong T, Wallace CL, Li SH et al (2006). Bupropion reduces methamphetamine-induced subjective effects and cue-induced craving. Neuropsychopharmacology 31: 1537-1544.
33. Silber BY, Croft RJ, Papafotiou K, Stough C (2006). The acute effects of d-amphetamine and methamphetamine on attention and psychomotor performance. Psychopharmacology 187: 154-169.
34. Silverman K, Kirby KC, Griffiths RR (1994a). Modulation of drug reinforcement by behavioral requirements following drug ingestion. Psychopharmacology 114: 243-247.
35. Silverman K, Mumford GK, Griffiths RR (1994b). Enhancing caffeine reinforcement by behavioral requirements following drug ingestion. Psychopharmacology 114: 424-432.
36. Stoops WW, Lile JA, Fillmore MT, Glaser PEA, Rush CR (2005a). Reinforcing effects of methylphenidate: influence of dose and behavioral demands following drug administration. Psychopharmacology 177: 349-355.
37. Stoops WW, Lile JA, Fillmore MT, Glaser PEA, Rush CR (2005b). Reinforcing effects of modafinil: influence of dose and behavioral demands following drug administration. Psychopharmacology 182: 186-193.
38. Wesnes K, Warburton DM (1983). Effects of smoking on rapid information processing performance. Neuropsychobiology 9: 223-229.
39. Wiegmann DA, Stanny RR, McKay DL, Neri DF, McCardie AH (1996). Methamphetamine effects on cognitive processing during extended wakefulness. Int J Aviat Psychol 6: 379-397.